Skip to main content Skip to main navigation menu Skip to site footer

Karakteristik penderita tuberkulosis paru relapse yang berobat di poli paru RSUP Sanglah Denpasar Bali periode Mei 2017 hingga September 2018


Introduction: Relapse pulmonary tuberculosis (TB) is a TB patient who has previously received TB treatment, and has been declared cured or complete treatment, was re-diagnosed with positive smear TB based on swab examination or culture. In Indonesia there are many cases of repeat treatment. 70% of them are relapse cases. So that research on the characteristics of pulmonary TB patients relapse is important. 

Method: This research is a cross sectional descriptive study where the source of the data comes from secondary data, namely medical records of patients with pulmonary TB patients relapse in pulmonary outpatient clinics at Sanglah General Hospital period May 2017 until September 2018.

Result: The results of this study showed that there were 40 patients proven to have pulmonary TB relapse. Most of the patients have ages of 50 to 59 years (25.0%), male sex (55.0%), last education in high school (57.5%), as many as 27.5% of them work as entrepreneurs and 27.5% do not work , the range of BMI in relapse pulmonary TB patients is 13-31 kg / m2 to 28.04 kg / m2 with an average of 19.54 + 3.03 kg / m2, the most clinical complaints are cough (80%), the most common comorbidities are pneumonia (15%) and based on thorax X-ray results found that the most finding was a picture of pleural effusion (22.5%).

Conclusion: Based on demographic characteristics, relapse pulmonary TB patients were dominated by age + 50 years with male sex, highschool education status, dominant in patients who did not work and had a low BMI. Based on clinical symptoms, coughing up phlegm, coughing up bleeding and chest tightness are common symptoms. Based on the accompanying comorbidities, pneumonia and heart failure that most often accompanying disease. The most common X-ray image found in relapse pulmonary TB patients is the presence of pleural effusion.


  1. Departemen Kesehatan Republik Indonesia. Pedoman Nasional Penanggulangan Tuberkulosis. Jakarta: Depkes RI, 2005
  2. World Health Organization. (2013) Global tuberkulosis control: WHO report (WHO/HTM/TB/2013.11). Geneva: 2013.
  3. World Health Organization. (2008). Anti-tuberkulosis drug resistance in the world. Report No. 4. Geneva: World Health Organization; 2008.
  4. Departemen Kesehatan Republik Indonesia. Pedoman Nasional Penanggulangan Tuberkulosis. Jakarta: Depkes RI. 2014
  5. Rohmad. Faktor Risiko Terjadinya Relapse pada Penderita Tuberkulosis Paru di Balai Besar Kesehatan Paru Masyarakat (BBPKM) Surakarta [SKRIPSI]. Surakarta: Universitas Muhammadiyah Surakarta. 2012.
  6. Sianturi R. Analisis Faktor yang Berhubungan dengan Kekambuhan TB Paru [SKRIPSI]. Semarang: Universitas Negeri Semarang.
  7. Karminiasih NLP, Putra IWG, Duarsa D. Risk Factors for Reccurences of Pulmonary TB among Patients in Denpasar: A Case Control Study. Public Health and Preventive Medicine Archive. 2016;4(1):20-25.
  8. Jo KW, Yoo JW, Hong Y. Risk factors for 1-Year Relapse of Pulmonary Tuberculosis Treated with a 6-Month Daily Regimen. Respiratory Medicine. 2014;108:654-659.
  9. Lee H, Kim J. A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data. Osong Public Health Res Respect. 2014;5(5):58-97.
  10. Pedro F, Carlos J, Anandi M, Francoise P. MODS Assay for The Diagnosis of Tuberkulosis. New England Journal of Medicine. 2007;356:188-189.
  11. Adane AA, Alene KA, Koye DN, Zeleke BM. Non- adherence to Anti-Tuberkulosis Treatments and Determinant Factors among patients with Tuberkulosis in Northwest Ethiopia. PLoS ONE. 2013;8(11): e78791.
  12. Khan A, Sterling T, Revees R, Vernon A. Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial. Am J Respir Crit Care Med. 2016;174:334-348.
  13. Bark C, Dietze R, Okwera A, Quelapo M. Clinnicalsymptoms and microbiological outcomes in tuberculosis treatment trials. Tuberculosis. 2011;35:601-604.
  14. Hussain T. Tuberculous pleural effusion – relapse or re-infection? Follow up of a case report and review of the literature. Egyptian Journal of Chest Disease and Tuberculosis. 2016;65:859-861.
  15. Cherian A, Thomas S. Central nervous system tuberculosis. African Health Science. 2011;11(1):116-128.
  16. Chang T, Mou C, Shen T. Retrospective cohort evaluation on risk of pneumonia in patients with pulmonary tuberculosis. Medicine. 2016;95(26):1-6.
  17. Gadoev J, Asadov D, Harries A. Recurrent Tuberculosis and Associated Factors: a Five – Year Countrywide Study in Uzbekistan. Plos One. 2017;12(5):e43267.
  18. Colangeli R, Kim S, Jedrey H, Connel R, Venkata C. Bacterial Factors That Predict Relapse after Tuberculosis Therapy. The New England Journal of Medicine. 2018;379(9):823-833.
  19. Kusumawati R, Tania T, McNeil E, Chongsuvivatwong V. Predictors of multidrug resistance among pulmonary tuberculosis patients in a tertiary hospital in North Sumatera, Indonesia. Bali Medical Journal. 2018;7(1):68-73. DOI:10.15562/bmj.v7i1.813

How to Cite

Widyastuti, N. N. A., Bagiada, I. M., & Andrika, P. (2019). Karakteristik penderita tuberkulosis paru relapse yang berobat di poli paru RSUP Sanglah Denpasar Bali periode Mei 2017 hingga September 2018. Intisari Sains Medis, 10(2).




Search Panel

Ni Nyoman Adi Widyastuti
Google Scholar
ISM Journal

I Made Bagiada
Google Scholar
ISM Journal

Putu Andrika
Google Scholar
ISM Journal